Kadcyla: NICE disappointed by manufacturer's decision

[News]

The National Institute for Health and Care Excellence (NICE) is very disappointed that Roche, the manufacturer of Kadcyla (trastuzumab emtansine) has decided not to offer its new treatment at a...

More... (http://www.medicalnewstoday.com/releases/280825.php)